Influence of perceived barriers and facilitators for physical activity on physical activity levels in patients with rheumatoid arthritis or spondyloarthritis: a cross-sectional study of 150 patients.
Axial Spondyloarthritis
Barriers and facilitators
Patient reported outcome measures
Physical activity
Psoriatic arthritis
Rheumatoid arthritis
Journal
BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565
Informations de publication
Date de publication:
30 Oct 2021
30 Oct 2021
Historique:
received:
27
04
2021
accepted:
15
10
2021
entrez:
31
10
2021
pubmed:
1
11
2021
medline:
3
11
2021
Statut:
epublish
Résumé
Barriers and facilitators to physical activity in inflammatory arthritis can be assessed through the Inflammatory arthritis FAcilitators and Barriers (IFAB) questionnaire. The objective was to measure the correlation between IFAB and self-reported physical activity levels. This was an international, multicentric, cross-sectional study in 2019-20. Consecutive spondyloarthritis (axSpA), rheumatoid arthritis (RA) or psoriatic arthritis (PsA) patients completed the 10-item IFAB, which ranges from - 70 to 70 with lower scores indicating more barriers. Physical activity was measured by the IPAQ-S questionnaire, steps per day collected by smartphone, and psychological readiness to change by stages of behaviour change. Spearman correlations and multivariable linear regression were calculated. Of 245 patients included, 150 were analysed: 69 (46%) axSpA, 63 (42%) RA, 18 (12%) PsA. Mean age was 48.6 years (standard deviation, SD 17.1), mean disease duration 11.7 (10.1) years and 60% were women. Barriers to physical activity were moderate: mean IFAB, 6 (SD 19.2); 39 (26%) patients scored less than - 5, corresponding to significant barriers. The mean physical activity was 2837 (SD 2668, median 1784) MET-minutes per week. The IPAQ-S questionnaire was correlated with the IFAB (rho 0.28, p < 0.001), as well as the stage of behaviour change (rho 0.35, p < 0.001) though not with steps per day. Multivariable analyses were confirmatory. Perceived barriers and facilitators to physical activity were correlated with physical activity, indicating that targeting patients with high barriers and low facilitators to physical activity could be an effective option to improve physical activity levels. ClinicalTrial NCT04426747 . Registered 11 June 2020 - Retrospectively registered.
Sections du résumé
BACKGROUND
BACKGROUND
Barriers and facilitators to physical activity in inflammatory arthritis can be assessed through the Inflammatory arthritis FAcilitators and Barriers (IFAB) questionnaire. The objective was to measure the correlation between IFAB and self-reported physical activity levels.
METHODS
METHODS
This was an international, multicentric, cross-sectional study in 2019-20. Consecutive spondyloarthritis (axSpA), rheumatoid arthritis (RA) or psoriatic arthritis (PsA) patients completed the 10-item IFAB, which ranges from - 70 to 70 with lower scores indicating more barriers. Physical activity was measured by the IPAQ-S questionnaire, steps per day collected by smartphone, and psychological readiness to change by stages of behaviour change. Spearman correlations and multivariable linear regression were calculated.
RESULTS
RESULTS
Of 245 patients included, 150 were analysed: 69 (46%) axSpA, 63 (42%) RA, 18 (12%) PsA. Mean age was 48.6 years (standard deviation, SD 17.1), mean disease duration 11.7 (10.1) years and 60% were women. Barriers to physical activity were moderate: mean IFAB, 6 (SD 19.2); 39 (26%) patients scored less than - 5, corresponding to significant barriers. The mean physical activity was 2837 (SD 2668, median 1784) MET-minutes per week. The IPAQ-S questionnaire was correlated with the IFAB (rho 0.28, p < 0.001), as well as the stage of behaviour change (rho 0.35, p < 0.001) though not with steps per day. Multivariable analyses were confirmatory.
CONCLUSION
CONCLUSIONS
Perceived barriers and facilitators to physical activity were correlated with physical activity, indicating that targeting patients with high barriers and low facilitators to physical activity could be an effective option to improve physical activity levels.
TRIAL REGISTRATION
BACKGROUND
ClinicalTrial NCT04426747 . Registered 11 June 2020 - Retrospectively registered.
Identifiants
pubmed: 34717606
doi: 10.1186/s12891-021-04792-7
pii: 10.1186/s12891-021-04792-7
pmc: PMC8556961
doi:
Banques de données
ClinicalTrials.gov
['NCT04426747']
Types de publication
Clinical Trial
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
915Informations de copyright
© 2021. The Author(s).
Références
JAMA. 2015 Feb 10;313(6):625-6
pubmed: 25668268
Nat Rev Rheumatol. 2018 Jun;14(6):363-371
pubmed: 29752461
BMJ Open. 2017 Dec 26;7(12):e017042
pubmed: 29282257
Eur J Appl Physiol. 2009 Apr;105(6):823-8
pubmed: 19205725
RMD Open. 2019 Apr 20;5(1):e000912
pubmed: 31168415
Int J Behav Nutr Phys Act. 2011 Oct 21;8:115
pubmed: 22018588
Am J Epidemiol. 2016 Nov 1;184(9):621-632
pubmed: 27760774
Ann Rheum Dis. 2016 May;75(5):811-8
pubmed: 26269398
Arthritis Rheum. 1995 Jan;38(1):44-8
pubmed: 7818570
Ann Rheum Dis. 2017 Jun;76(6):978-991
pubmed: 28087505
Joint Bone Spine. 2021 Mar;88(2):105137
pubmed: 33484861
Clin Rheumatol. 2015 Feb;34(2):231-8
pubmed: 24213780
BMC Rheumatol. 2018 Sep 6;2:25
pubmed: 30886975
Rheumatol Int. 2020 Dec;40(12):2085-2095
pubmed: 32862307
Rheumatology (Oxford). 2018 Dec 1;57(12):2172-2182
pubmed: 30107595
Sports Med. 2017 Jul;47(7):1303-1315
pubmed: 28005190
Nat Rev Rheumatol. 2012 Nov;8(11):656-64
pubmed: 23007741
J Clin Epidemiol. 2005 Jun;58(6):595-602
pubmed: 15878473
Res Q Exerc Sport. 1992 Mar;63(1):60-6
pubmed: 1574662
Ann Rheum Dis. 2009 Jun;68(6):777-83
pubmed: 19297344
ACR Open Rheumatol. 2020 Oct;2(10):582-587
pubmed: 32985797
Lancet. 2012 Jul 21;380(9838):193-5
pubmed: 22818934
Arthritis Rheum. 2006 Aug;54(8):2665-73
pubmed: 16871531
J Sports Sci. 2018 Aug;36(15):1695-1704
pubmed: 29179653
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Appl Physiol Nutr Metab. 2013 Feb;38(2):100-14
pubmed: 23438219
PLoS One. 2014 Feb 28;9(2):e85309
pubmed: 24586239
Arthritis Care Res (Hoboken). 2020 Sep 4;:
pubmed: 32886866
Int J Behav Nutr Phys Act. 2011 Jul 28;8:80
pubmed: 21798044
Joint Bone Spine. 2018 May;85(3):275-284
pubmed: 29407043
Health Psychol Rev. 2016 Dec;10(4):478-494
pubmed: 27265062
BMJ Open. 2016 Feb 03;6(2):e010064
pubmed: 26842273
Am J Prev Med. 2002 May;22(4 Suppl):73-107
pubmed: 11985936
BMJ. 2012 Mar 26;344:e1389
pubmed: 22451477
Clin Rheumatol. 2019 Sep;38(9):2483-2491
pubmed: 31037458
Womens Health Issues. 2011 Jan-Feb;21(1):57-63
pubmed: 20833069
Br J Sports Med. 2014 Feb;48(3):220-5
pubmed: 24002240
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
Musculoskeletal Care. 2019 Jun;17(2):163-173
pubmed: 30729653
JMIR Mhealth Uhealth. 2018 Jan 02;6(1):e1
pubmed: 29295810
Rheumatology (Oxford). 2014 Oct;53(10):1812-7
pubmed: 24829221
Ann Rheum Dis. 2010 Feb;69(2):325-31
pubmed: 19773290
Arthritis Care Res (Hoboken). 2019 Jun;71(6):839-851
pubmed: 30004189